abstract |
The present invention relates to compounds of formula (I) and to their pharmaceutically acceptable salts and solvates, and to processes for their preparation, to intermediates used in their preparation, to compositions containing them and to the uses of such compounds as agonists of the receptor of the adenosine A2a. |